Page results
-
The head and neck speech and language therapy team provide a highly specialist service to both inpatients and outpatients who may experience difficulty swallowing or speaking following treatment for head and neck cancer.
-
Professor Hough is a consultant heamatologist at UCLH. She has specialist expertise in the management of acute lymphoblastic leukaemia in teenagers and young adults, and the use of umbilical cord blood as an alternative source of haemopoietic stem cells.
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
Information about the COVID-19 clinics available at UCLH.
-
UCLH patient information for using Control IQ technology
-
Dr Nagendran is a consultant neurophysiologist eripheral nerve and muscle disease, skeletal muscle channelopathies, nerve excitability disorders
-
This page provides general information about care of wounds following spinal surgery.
-
UCLH runs a programme of GP education seminars designed to keep primary care teams updated with all our services and specialties.
-
This information is intended for patients who are receiving GnRH-a injections as part of their treatment at UCLH.
-
The Preterm Birth Clinic is one of a few UK specialist antenatal services that are designed specifically for the needs of pregnant women at risk of premature labour.
File results
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment
-
FOI/2022/0540 - Electronic patient record
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm
-
FOI/2022/0576 - Medications within dermatology